Value sales of analgesics continue to rise in Australia in 2022 following a particularly strong performance the previous year when demand was partly driven by the ongoing effects of the pandemic and stockpiling tendencies.
The Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Analgesics in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market
- Pinpoint growth sectors and identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
ANALGESICS IN AUSTRALIAKEY DATA FINDINGS
2022 DEVELOPMENTS
- Rise in common colds and illnesses post-pandemic leads to further demand for analgesics in Australia
- Panic buying continues to place pressure on supply chain of analgesics
- Reckitt Benckiser (Australia) Pty Ltd launches next generation of Nurofen with Nurofen Meltlets
- Growth rates to gradually normalise over forecast period but demand will remain high despite rising unit prices
- Associated harmful side effects could trigger more conservative use of analgesics
- Chronic pain expected to rise over the forecast period contributing to sales of analgesics
- Table 1 Sales of Analgesics by Category: Value 2017-2022
- Table 2 Sales of Analgesics by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Analgesics: % Value 2018-2022
- Table 4 LBN Brand Shares of Analgesics: % Value 2019-2022
- Table 5 Forecast Sales of Analgesics by Category: Value 2022-2027
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2021-2022
DEFINITIONS
SOURCES
- Summary 2 Research Sources